Klea HoldingSTU:7V91 +2.55%44 Net Margin % is 10.71% as of Dec. 2025. GuruFocus rates STU:7V91 with a GF Score™ of 44/100 and a GF Value™ of €0.32 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, Klea Holding ranks better than 76.35% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Klea Holding's Net Income for the
six
months ended in Dec. 2025 was €1.15 Mil. Klea Holding's Revenue for the
six
months ended in Dec. 2025 was €10.71 Mil. Therefore, Klea Holding's net margin for the quarter that ended in Dec. 2025 was 10.71%.
The historical rank and industry rank for Klea Holding's Net Margin % or its related term are showing as below:
STU:7V91'
s Net Margin % Range Over the Past 10 Years
Min: -234.96 Med: -49.34 Max: 10.29
Current: 10.29
STU:7V91's Net Margin % is ranked better than 76.35% of 203
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.43
vs STU:7V91: 10.29
Klea Holding (STU:7V91) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Klea Holding Net Margin % Related Terms
Klea Holding Net Margin % Historical Data
* Premium members only.
The historical data trend for Klea Holding's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:7V91 vs TMO, DHR, IDXX: Net Margin % Comparison
For the Diagnostics & Research subindustry, Klea Holding's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Klea Holding Net Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Klea Holding's Net Margin % distribution charts can be found below:
* The bar in red indicates where Klea Holding's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Klea Holding (STU:7V91) has a Net Margin % of 10.71% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Klea Holding and its competitors. According to the industry distribution chart, Klea Holding ranks #48 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 23.6%.
Is Klea Holding's Net Margin % too high?
Klea Holding's current Net Margin % is 10.71%. Based on the distribution chart, Klea Holding ranks #48 out of 203 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Klea Holding has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Klea Holding's Net Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Klea Holding ranks #48 out of 203 companies for Net Margin %. This places Klea Holding in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Klea Holding and its competitors. Klea Holding's current Net Margin % is 10.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Klea Holding stock overvalued right now?
Based on GuruFocus' analysis, Klea Holding (STU:7V91) is currently considered Possible Value Trap. The stock's GF Value™ is €0.32, compared to a current price of €0.18 — trading 44.8% below its estimated fair value. The current Net Margin % is 10.71%. Klea Holding's overall GF Score™ is 44/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Klea Holding (STU:7V91), the current Net Margin % is 10.71% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Klea Holding (STU:7V91) Overvalued in 2026?
Based on GuruFocus' analysis, Klea Holding stock appears to be undervalued.
The current stock price of €0.18 is trading 44.8% below its estimated GF Value™ of €0.32.
GuruFocus considers Klea Holding to be Possible Value Trap.
Key valuation signals for STU:7V91:
Net Margin %: 10.71%
GF Value™: €0.32 vs. price of €0.18 (44.8% below fair value)
No single metric tells the full story. See the STU:7V91 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Klea Holding focused on the acquisition, development and digitalization of companies in multiple sectors. Its development of Smart Salem, the first network of digital medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the Emirates United Arabs, or its Smart Health joint venture developed in Saudi Arabia.
44GF Score
Get the complete analysis for STU:7V91
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:7V91 has been successfully added to your 
